
Opinion|Videos|July 17, 2024
Overcoming Treatment Barriers in Vitiligo: From Insurance Coverage to Patient Adherence
Author(s)Andrew F. Alexis, MD, MPH
Andrew Alexis, MD, MPH, reviews the case of a 66-year-old woman who presented with depigmented patches and provides clinical insights on barriers typically encountered during the management of this condition.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- Where would you go from here, treatment-wise?
- What is your experience combining topical therapy with NB-UVB phototherapy?
- What are the unique challenges and benefits of using narrowband UVB phototherapy for vitiligo in patients with darker skin color?
- How do you manage the logistical challenges patients might face with frequent phototherapy sessions?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Galderma’s BLA Resubmission for Liquid Neuromodulator RelabotulinumtoxinA
2
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
3
Introducing Dermatology Times NP/PA Connect
4
Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis
5













